PEDIATRICS Vol. 102 No. 6 December 1998, p. e66

ELECTRONIC ARTICLE:
Cardiac Sequelae in Recurrent Cases of Kawasaki Disease: A Comparison Between the Initial Episode of the Disease and a Recurrence in the Same Patients

Yosikazu Nakamura, Izumi Oki, Shinichi Tanihara, Toshiyuki Ojima, and Hiroshi Yanagawa

From the Department of Public Health, Jichi Medical School, Tochigi, Japan.

	ABSTRACT

Top Abstract Materials & Methods Results Discussion References

Objective.  Cardiac sequelae develop more frequently after recurrent Kawasaki disease than from the initial onset of the disease. The purpose of this study was to observe the existence of the sequelae at the initial and second onsets of the disease simultaneously with a large cohort.

Materials and Methods.  From the database of patients with Kawasaki disease prepared by the Japanese Kawasaki Disease Research Committee, 559 cases with recurrences recorded between 1989 through 1994 and their initial occurrence listed in the database were selected. Their proportions of cardiac sequelae after the initial and second onsets of Kawasaki disease were compared.

Results.  Of the 68 patients with cardiac sequelae after the initial onset, 32 (47%) suffered the sequelae after the second onset, whereas 78 (16%) of the 491 who were without cardiac sequelae after the initial onset developed the sequelae after the recurrence. Both proportions were higher than proportions in all patients with Kawasaki disease. In addition to the sex (male) and the existence of the sequelae after the initial onset, age at the second onset (older age) and the interval between the two episodes (longer period) were suspected to be risk factors for sequelae attributable to recurrent Kawasaki disease.

Conclusion.  Linked data of the initial and second episodes of Kawasaki disease showed that the risk of developing cardiac sequelae attributable to recurrent Kawasaki disease is high among both those with and without the sequelae at the initial episode. mucocutaneous lymph node syndrome, recurrence, cardiac sequelae, risk factors. .

Cardiac sequelae attributable to Kawasaki disease constitute one of the serious problems associated with the disease,¹ and their risk factors have been discussed.^2,3 One of the interesting features of the disease is its recurrence.^4,5 Nationwide surveys of the disease in Japan showed that the disease recurs in ~3%.^6,7 Some have reported the relationship between the cardiac sequelae and the recurrence of Kawasaki disease, but the data from the Japanese nationwide survey were used in only one study, which examined the aforementioned relationship in a large population.⁸ The study showed that cardiac sequelae occur more frequently after a recurrence of Kawasaki disease than after the initial episode. However, the study had a disadvantage: it compared the proportion of the sequelae only between the patient group with the initial episode of the disease and the group with recurrent attacks, but no linkage between the first and second episodes was conducted.

In this study, data from the nationwide epidemiologic surveys on patients with recurrent Kawasaki disease are provided to elucidate the details of the development of cardiac sequelae at the initial and second episodes.

	MATERIALS AND METHODS

Top Abstract Materials & Methods Results Discussion References

The Japanese Kawasaki Disease Research Committee has a database of 128 306 patients in Japan with Kawasaki disease. All the patients were reported in the 13 nationwide surveys of the disease conducted by the committee. From this database, 1053 recurrent cases reported in the three most recent surveys were selected. The 11th, 12th, and 13th surveys were conducted for patients diagnosed between 1989 and 1990,⁹ 1991 and 1992,¹⁰ and 1993 and 1994,⁷ respectively.

We tried to link these data of 1053 recurrent cases and 128 306 cases, using the date of birth and sex, after which we identified the patients by name. Of the 1053 recurrent cases, 327 could not be linked because some were not registered by name; 57 were excluded because this was the third (54 cases) or fourth (3 cases) recurrence; and 41 were suffering from reexacerbation of the disease but not recurrence (because the interval between the onsets of the two episodes was within 2 months⁵). Other reasons, such as no data on cardiac sequelae collected in the nationwide surveys at the initial onset, excluded 36 cases, and an additional 30 patients were excluded because they visited the hospital on or after the 15th day from the onset of illness. Consequently, data for 559 cases were eligible for the analyses (Fig 1).

View larger version (26K): [in this window] [in a new window]   Fig. 1.   Methods to select study items, number of patients, and percentages (in parentheses) of patients with cardiac sequelae at the second episode, by group.

For the 559 cases observed, the following data were obtained from the nationwide survey database: the date of birth; sex; and information on the disease for the initial and second episodes such as date of onset, treatment, and presence (or absence) of cardiac sequelae. Age at onset and the interval between the two episodes were calculated using these data. Cardiac sequelae were defined in the nationwide surveys as one of the following findings after a 1-month period from onset: coronary aneurysms including dilatation, coronary stenosis including narrowing, myocardial infarction, and valvular lesions.^7,11,12 In addition, the 12th and 13th surveys had detailed data on whether an individual patient had each of the sequelae noted above.⁶ In Japan, giant coronary aneurysms are defined as those with a diameter of 8 mm, measured on two-dimensional echocardiography and/or coronary angiography.¹³

First, we observed the relationship between the initial and second episodes in relation to cardiac sequelae by factors such as sex, age at initial episode, and interval between the two episodes. Second, each type of sequela (such as giant coronary aneurysms, coronary aneurysms including dilatation, coronary stenosis including narrowing, myocardial infarction, and valvular lesions) was analyzed for the 259 cases on which detailed data were available (the data were required for the 12th and succeeding surveys). Next, the odds ratios with 95% confidence intervals for the cardiac sequelae in the second episode were calculated with unconditional logistic models, using the LOGISTIC procedure of SAS.¹⁴ Finally, to assess a selection bias attributable to the exclusion, we examined the proportion of cardiac sequelae of 494 recurrent cases that had been excluded.

	RESULTS

Top Abstract Materials & Methods Results Discussion References

The distributions of age at the initial and second onsets and the interval between the two episodes of the 559 cases (333 males and 226 females) are shown in Table 1. The average interval between the two episodes was 1.78 years.

Table 2 shows the development of cardiac sequelae for each episode. Overall, 68 (12.2%) of the 559 patients developed cardiac sequelae at the initial episode, and 32 (41.7%) of the 68 also experienced the sequelae after the second episode. On the other hand, 78 (15.9%) of the 491 that did not have the sequelae at the initial episode developed them at the second episode. This figure of 15.9% is higher than the corresponding recent figure (12.8%) for the overall patient population with Kawasaki disease in Japan.⁷ Similar results were observed in the analyses by sex and age. Males with Kawasaki disease are more likely to develop cardiac sequelae than are females.⁷ This tendency also was observed in the development after the initial episode and after the second episode in those who did not experience the sequelae after the initial episode. However, among those with cardiac sequelae after both the initial and the second episodes, the proportion was nearly equal in males and females (45.8% and 50.0%, respectively). Among those who developed the sequelae for the first time after the second episode, such a development was more likely when the disease returned after 1 year in comparison with those with a recurrence within 1 year. Age at the initial onset did not affect the risk of development of the sequelae at the second episode.

The results of analyses on 259 cases that were reported in the 12th and 13th surveys (when detailed data on sequelae were recorded) are shown in Table 3. Of the 231 patients without sequelae at the initial episode, 27 developed coronary aneurysms (2 with giant aneurysms). Of the 22 patients with coronary aneurysms at the initial episode, the incidences were reported in 13 after the second episode. Interestingly, 4 patients had giant coronary aneurysms at the second episode: 2 had giant aneurysms also at the initial episode, whereas the other 2 were free from the sequelae at the initial onset.

The results of logistic regression analyses are shown in Table 4. Sex and the existence of cardiac sequelae at the initial episode were significant risk factors for development of the sequelae at the second episode. Moreover, a longer interval between the two episodes and an older age group at the second episode were suspected risks, even though they were not significant. The results of the multiple logistic analysis that included all of the factors were comparable with those obtained from the crude analyses.

For this study, only 559 cases of recurrent Kawasaki disease were selected from 1053 patients reported in the 11th through 13th nationwide surveys, therefore, selection bias may have distorted the results. To evaluate any bias, we compared the proportion of cardiac sequelae at the second episode between the patient group of this study and those who were excluded. The proportions were similar among the groups (Fig 1).

	DISCUSSION

Top Abstract Materials & Methods Results Discussion References

In this study, we have shown that in approximately half of the cases with cardiac sequelae at the initial episode of Kawasaki disease, the sequelae existed after the second episode of the disease. In addition, even among those patients without cardiac sequelae at the initial episode, the risk of development is greater than that for the overall patient population with Kawasaki disease.

In the nationwide surveys of the disease, cardiac sequelae are defined as specific cardiac findings 1 month after the onset.^11,12 In approximately half of the recurrent cases with the sequelae at the initial episode, the sequelae did not exist after the second episode. This fact indicates that more than half of the sequelae, which existed at least 1 month after the onset of initial episode, were no longer present. It is well known that some coronary aneurysms attributable to Kawasaki disease regress,^115-17 and the current results corroborate this. Even in three of the five cases with giant aneurysms at the initial episode did size decrease, and the aneurysms became small or medium-sized at the second episode.

On the other hand, the other half of patients with the sequelae at the initial episode had the sequelae after the second episode as well, a finding that is also plausible. Host factors, ie, susceptibility to vasculitis attributable to Kawasaki disease, may exist because only ~10% to 15% of the patients develop the sequelae,⁷ and half of these had them again if they recur.

Compared with the total patient population with Kawasaki disease in Japan, the recurrence of the disease is more likely to include the development of cardiac sequelae whether or not the sequelae were present at the initial episode. This finding is plausible because repeated assaults by vasculitis associated with Kawasaki disease are more likely to have greater effect than would an isolated assault.⁸

Giant coronary aneurysms are the most serious outcome of Kawasaki disease. The relationship between the initial and second episodes for the development of coronary aneurysms is interesting (Fig 2). None of the small or medium-sized coronary aneurysms, including coronary dilatation, at the initial episode progressed to a giant aneurysm at the second episode. For the 2 patients with giant aneurysms at both the initial and second episodes, it is certain that the giant aneurysms at the initial episode continued to endure until the second episode, even though they might have become smaller between the two episodes, and grew to become giant aneurysms again at the second episode. The other 2 patients with giant aneurysms at the second episode did not have them at the first episode. In other words, small or medium-sized coronary aneurysms seen in the 22 patients at the initial episode did not progress to become giant aneurysms when the disease returned. These results indicate that giant aneurysms attributable to recurrent Kawasaki disease are those that have existed since the initial episode or had developed without any sign at the initial episode.

View larger version (19K): [in this window] [in a new window]   Fig. 2.   Relationship between changes in the coronary arteries attributable to the initial and second episodes of Kawasaki disease.

Risk factors for the sequelae at the second episode of Kawasaki disease are male sex and the existence of the sequelae at the initial onset. Our findings substantiated this. In addition, it was suspected that a long interval between the two episodes and older age at the second episode were risk factors, even though they were not proven to have statistical significance. If a patient experiences a recurrence of Kawasaki disease long after the initial episode, the patient will have advanced to an older age group. For example, if the interval between the two episodes is 5 years, the patient must be at least 5 years old. Thus, the two factors relate to each other. The multiple logistic analysis, however, showed that the two factors might affect the existence of the sequelae at the second episode independently. According to the nationwide surveys in Japan, cardiac sequelae are more common among those 5 years old,⁷ thus, older age is a risk factor not only for cardiac sequelae attributable to recurrent Kawasaki disease but also for all sequelae attributable to the disease. On the other hand, we have no theory to link the proportional increase in the probability for the existence of the sequelae with the prolongation of the interval between the two episodes.

This study has limitations. By using epidemiologic survey data, information that could be obtained on the two episodes was limited, and no information on what might have happened between the episodes was available. Therefore, we are not able to provide answers to some interesting questions, such as the persistence or state of a cardiac sequela at some time between the two episodes or whether there was an improvement at the second episode when it existed in both the initial and second episodes. In addition, there is no information on whether the coronary aneurysms at the second episode were in the same or different arteries. Despite the limitations, however, the sample size was large enough to permit the present observation to be made.

Another drawback was a possibility of selection bias. For some reasons, complete data linkage was not possible, or some data were not available; therefore, only 559 (53.1%) of 1053 cases were available for examination. However, proportions of cardiac sequelae at the second episode were similar in the selected group and in the overall patient population (Fig 1). The effect of the bias was minimal, if it existed at all.

In conclusion, linking the data for initial and second episodes of Kawasaki disease has shown that the risk of cardiac sequelae attributable to recurrent Kawasaki disease is high both in those with and in those without the sequelae at the initial episode.

	FOOTNOTES

Received for publication Feb 10, 1998; accepted Jul 14, 1998.

Reprint requests to (Y.N.) Department of Public Health, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Tochigi 329-0498 Japan.

	ACKNOWLEDGMENT

This study was conducted as a research project by the Japanese Kawasaki Disease Research Committee and was supported financially by the Ministry of Health and Welfare of the Japanese Government.

	REFERENCES

Top Abstract Materials & Methods Results Discussion References

1. Kato H, Sugimura T, Akagi T, Long-term consequences of Kawasaki disease: a 10- to 20-year follow-up study of 594 patients. Circulation 1996; 94:1379-1385 [Abstract/Free Full Text]
2. Asai T Evaluation method for the degree of seriousness in Kawasaki disease. Acta Paediatr Jpn 1983; 25:170-175
3. Ishihara H, Izumida N, Hosaki J Criterion for early prediction of coronary artery involvement by clinical manifestations in patients with Kawasaki disease. Bull Tokyo Med Dent Univ 1985; 32:77-89 [Medline]
4. Mason WH, Takahashi M, Schneider T. Recurrence of Kawasaki disease in a large urban cohort in the United States. In: Takahashi M, Taubert K, eds. Proceedings of the Fourth International Symposium on Kawasaki Disease. December 1-4, 1991. Dallas, TX: American Heart Association; 1993:21-26
5. Nakamura Y, Yanagawa H A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan. Eur J Pediatr 1996; 155:303-307 [CrossRef][Medline]
6. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Harada K Results of the 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med 1995; 149:779-783 [Abstract]
7. Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Koyanagi H, Kawasaki T Update of the epidemiology of Kawasaki disease in Japan. J Epidemiol 1996; 6:148-157 [Medline]
8. Nakamura Y, Yanagawa H, Ojima T, Kawasaki T, Kato H Cardiac sequelae of Kawasaki disease among recurrent cases. Arch Dis Child 1998; 78:163-165 [Abstract/Free Full Text]
9. Nakamura Y, Yanagawa H, Kato H, Mortality rates for patients with a history of Kawasaki disease in Japan. J Pediatr 1996; 128:75-81 [CrossRef][Medline]
10. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics 1995; 95:475-479 [Abstract/Free Full Text]
11. Nakamura Y, Fujita Y, Nagai M, Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics 1991; 88:1144-1147 [Abstract/Free Full Text]
12. Hirose K, Nakamura Y, Yanagawa H Cardiac sequelae of Kawasaki disease in Japan over 10 years. Acta Paediatr Jpn 1995; 37:667-671 [Medline]
13. Kawasaki Disease Research Committee Guidelines for treatment and management of cardiovascular sequelae in Kawasaki disease. Acta Paediatr Jpn 1987; 29:109-114 [Medline]
14. SAS Institute Inc. SAS/STAT software: changes and enhancements. Cary, NC: SAS Institute Inc; 1996:381-490
15. Sasaguri Y, Kato H Regression of aneurysms in Kawasaki disease: a pathologic study. J Pediatr 1982; 100:225-231 [CrossRef][Medline]
16. Takahashi M, Mason W, Lewis AB Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 1987; 75:387-394 [Abstract/Free Full Text]
17. Sugimura T Coronary artery distensibility in Kawasaki disease: evaluation by intracoronary infusion of isosorbide dinitrate in long-term follow-up. Kurume Med J 1992; 38:317-325